0000950170-24-023374.txt : 20240229
0000950170-24-023374.hdr.sgml : 20240229
20240229183413
ACCESSION NUMBER: 0000950170-24-023374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saad Mark E
CENTRAL INDEX KEY: 0001295913
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 24705990
BUSINESS ADDRESS:
BUSINESS PHONE: 858-458-0900
MAIL ADDRESS:
STREET 1: C/O CYTORI THERAPEUTICS, INC.
STREET 2: 3020 CALLAN ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
ownership.xml
4
X0508
4
2024-02-27
0001579428
Axsome Therapeutics, Inc.
AXSM
0001295913
Saad Mark E
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
true
false
false
false
false
Stock Option (Right to Buy)
84.00
2024-02-27
4
A
false
1519
0.00
A
2024-02-27
2034-02-26
Common Stock
1519
1519
D
Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.
/s/ Herriot Tabuteau, M.D., Attorney in Fact
2024-02-29